Dialysis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dialysis stocks.

Dialysis Stocks Recent News

Date Stock Title
Oct 2 LMAT BAX vs. LMAT: Which Stock Is the Better Value Option?
Oct 2 ANGO AngioDynamics Q1 2025 Earnings Preview
Oct 2 DVA SRDX Stock Down Despite FDA Clearance for Pounce XL System
Oct 2 DVA 5 Stocks Trading Near 52-Week High With Room to Rise Further
Oct 1 DVA 3 Buy Rated Stocks Cruising at 52 Week Highs
Oct 1 SNY Update: Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
Oct 1 SNY Market Chatter: Sanofi Asks Bidders to Revise Offers for Consumer Health Unit
Oct 1 SNY Sanofi Is Said to Ask Bidders to Revise Consumer Health Offers
Oct 1 FMS Fresenius Medical Care (ETR:FME) earnings and shareholder returns have been trending downwards for the last three years, but the stock advances 4.8% this past week
Sep 30 SNY Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
Sep 30 DVA Is DaVita Inc.'s (NYSE:DVA) ROE Of 47% Impressive?
Sep 30 DVA Tempus Stock Up Following Collaboration Expansion in Oncology R&D
Sep 30 ANGO New Strong Buy Stocks for September 30th
Sep 29 LMAT LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals?
Sep 28 SNY Regeneron, Sanofi announce Dupixent approval in China for patients with COPD
Sep 27 SNY Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Sep 27 SNY Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
Sep 27 SNY Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
Sep 27 SNY Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Sep 27 SNY Sanofi, Regeneron get additional Chinese approval for Dupixent
Dialysis

In medicine, dialysis (from Greek διάλυσις, diàlysis, "dissolution"; from διά, dià, "through", and λύσις, lỳsis, "loosening or splitting") is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy.
Dialysis is used in patients with rapidly developing loss of kidney function, called acute kidney injury (previously called acute renal failure), or slowly worsening kidney function, called Stage 5 chronic kidney disease, (previously called chronic kidney failure and end-stage renal disease and end-stage kidney disease).
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible.In the United Kingdom and the United States, dialysis is paid for by the government for those who are eligible. The first successful dialysis was performed in 1943.
In research laboratories, dialysis technique can also be used to separate molecules based on their size. Additionally, it can be used to balance buffer between a sample and the solution "dialysis bath" or "dialysate" that the sample is in. For dialysis in a laboratory, a tubular semipermeable membrane made of cellulose acetate or nitrocellulose is used. Pore size is varied according to the size separation required with larger pore sizes allowing larger molecules to pass through the membrane. Solvents, ions and buffer can diffuse easily across the semipermeable membrane, but larger molecules are unable to pass through the pores. This can be used to purify proteins of interest from a complex mixture by removing smaller proteins and molecules.

Browse All Tags